Tradestie Institutional Equity Comparison Engine

ZJYL vs ZKH โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ZJYL Overall Edge

ZJYL Captures Institutional Edge (2โ€“1 Pillars ยท 6โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL) driven by superior Growth & Margin, Momentum & Technical while ZKH counters with relative strength in Valuation. Fundamentally, ZJYL trades at N/M Forward P/E with 2.1% operating margin (-9.7% YoY revenue) versus ZKH at 3.3x Forward P/E and -0.8% operating margin (+12.8% YoY). In options structure, ZJYL sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ZKH sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner ZKH
ZJYL N/M vs ZKH 3.3x Fwd P/E
Growth & Margin Winner ZJYL
Op Margin 2.1% vs -0.8% ยท YoY -9.7% vs +12.8%
Momentum & Technical Winner ZJYL
1Y +1097.1% vs -51.8% ยท 52W Pos 67% vs 10%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
ZJYL NASDAQ
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$3.34
-0.6% 1D
Market Cap $534.9M
1M Return +59.73%
1Y Return +1097.13%
Forward P/E N/M
Unified AI Score
40.6 / 100 SELL
Tech 24.0 Fund 31.0 Flow 50.0 Mom 54.0
ZKH NYSE
ZKH Group Limited American Depositary Shares, each representing thirty-five (35) Class A Ordinary Shares
Retail-Building Materials, Hardware, Garden Supply
$1.47
+4.26% 1D
Market Cap $222.5M
1M Return -16.95%
1Y Return -51.8%
Forward P/E 3.3x
Unified AI Score
48.9 / 100 HOLD
Tech 65.0 Fund 62.0 Flow 50.0 Mom 58.9

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ZJYL +1097.13% ZKH -51.8% Spread: +1188.84 pp (ZJYL Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ZJYL TTM Op. Margin: 2.1% ZKH TTM Op. Margin: -0.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ZJYL vs ZKH. Trailing 12-month operating profitability (ZJYL 2.1% vs ZKH -0.8%) and valuation multiples (ZJYL N/M vs ZKH 3.3x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ZJYL (6) vs ZKH (4)
Institutional Metric ZJYL ZKH Criterion Row Winner
Market Capitalization Scale $534.9M $222.5M Larger Scale ZJYL
Trailing P/E Ratio Valuation 17.7x 28.2x Lower Multiple ZJYL
Forward P/E Ratio Valuation N/M 3.3x Lower Multiple ZKH
Revenue Growth (YoY) Growth -9.7% +12.8% Higher Growth ZKH
Operating Margin (TTM) Profitability 2.1% -0.8% Higher Margin ZJYL
Net Profit Margin Profitability 5.9% -0.0% Higher Margin ZJYL
Return on Equity (ROE) Capital Efficiency 4.0% -0.1% Higher ROE ZJYL
52-Week Range Position Momentum 67% ($0โ€“$5) 10% ($1โ€“$4) Stronger Trend ZJYL
Beta / 30D Volatility Risk Regime 13.88ฮฒ ยท 178% Vol -0.20ฮฒ ยท 94% Vol Lower Realized Risk ZKH
Unified Institutional Score Composite Signal 40.6 / 100 (SELL) 48.9 / 100 (HOLD) Higher Composite ZKH

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ZJYL vs ZKH Buy Guide
ZJYL UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ZJYL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ZKH UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ZKH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ZJYL nor ZKH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.